论文信息 - S0536: Carboplatin, paclitaxel, cetuximab, and bevacizumab followed by cetuximab and bevacizumab maintenance in advanced non-small cell lung cancer (NSCLC): A SWOG phase II study. - 字舞流文

S0536: Carboplatin, paclitaxel, cetuximab, and bevacizumab followed by cetuximab and bevacizumab maintenance in advanced non-small cell lung cancer (NSCLC): A SWOG phase II study.

R. Herbst | F. Hirsch | K. Kelly | W. Franklin | S. Dakhil | J. Moon | P. Mack | D. Gandara | M. Redman | E. Kim